A Study to Evaluate Adverse Events and Effectiveness of OnabotulinumtoxinA in Participants Undergoing Open Abdominal Ventral Hernia Repair for the Achievement of Primary Fascial Closure Without the Use of Component Separation Technique
Conditions:   Ventral Hernia;   Abdominal Hernia Interventions:   Drug: BOTOX Dose A;   Drug: Placebo for BOTOX;   Drug: BOTOX Dose B;   Drug: BOTOX Dose C Sponsor:   AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2022 Category: Research Source Type: clinical trials

BOTOX Effects on Seizure Severity and Susceptibility
Condition:   Drug-resistant Focal Seizure Intervention:   Drug: OnabotulinumtoxinA 145 UNT [Botox] Sponsors:   Beth Israel Deaconess Medical Center;   AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 4, 2022 Category: Research Source Type: clinical trials